3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
4
Oropharyngeal Neoplasms
3
Laryngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Mouth Neoplasms
2
Mesothelioma
2
Hypopharyngeal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Astrocytoma
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Nasopharyngeal Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Carcinoma, Squamous Cell
1
Interventions
Cyclophosphamide
6
fludarabine
4
Standard of Care
4
Practice Guidelines as Topic
3
Mycophenolic Acid
3
GSK2636771
3
venetoclax
2
trametinib
2
talquetamab
2
osimertinib
2
dabrafenib
2
X-Rays
2
Whole-Body Irradiation
2
Thiotepa
2
Tacrolimus
2
Specimen Handling
2
Patient Navigation
2
Methods
2
Mesna
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
Educational Status
2
Early Intervention, Educational
2
Biopsy
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
thymoglobulin
1
sapanisertib
1
ruxolitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.